democratic lawmaker

Trump’s drugmaker deals may save economy $529B over 10 years, White House says

White House economists estimate that President Trump’s deals with pharmaceutical companies to drop some of their U.S. prescription drug prices to what they charge in other countries could save $529 billion over the next 10 years.

The analysis obtained by the Associated Press includes the first economy-wide projections behind a policy at the core of Trump’s pitch to voters going into November’s midterm elections for control of the House and Senate. Democratic lawmakers have been doubtful about the savings claimed by Trump and these new numbers are likely to trigger additional questions about the data.

Cost-of-living issues are at the forefront of voters’ concerns and higher energy prices tied to the Iran war have deepened the public’s anxiety. Trump has tried in part to address affordability concerns by focusing on his efforts to cut deals with companies so that the cost of prescription drugs in the U.S. would no longer be dramatically higher than in other affluent nations.

“Now you have the lowest drug prices anywhere in the world,” Trump said at a Friday rally before a crowd of seniors in Florida. “And that alone should win us the midterms.”

The analysis was done by administration officials for the White House Council of Economic Advisers. They also estimated that federal and state governments could save a combined $64.3 billion on Medicaid during the next decade because of what Trump calls his “most favored nation” policy on drug prices.

Few of the details of the deals struck by the Trump administration and 17 leading pharmaceutical companies have been made public, making it hard to independently verify the projected savings. The White House analysis sought to estimate the prospective savings as more medications come onto the market and fall under Trump’s framework — with one model in the report tallying the possible savings at $733 billion over a decade.

Trump and his Department of Health and Human Services have touted his drug-pricing deals as transformative and urged Congress to codify their principles into law. Democratic lawmakers have challenged the administration’s claims of savings. Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and 17 Senate Democrats in April proposed a measure requiring the administration to disclose the terms of the agreements signed by pharmaceutical companies.

“If these deals are so great, why is the Trump administration afraid of showing them to the public?” Wyden said when announcing the measure. Health Secretary Robert F. Kennedy Jr. said his team would share details that didn’t include proprietary information or trade secrets.

The White House said it has not shared the text of the agreements because they include highly sensitive data that could move financial markets.

The potential savings estimated by the Trump administration would be substantial as Americans spent $467 billion on prescription drugs in 2024, according to the most recent government data available. The analysis is premised on the idea that foreign countries would also pay more for their prescription drugs, which would diversify drugmakers’ sources of revenue and preserve their ability to innovate with new treatments.

Outside economists have caveated that any savings might not flow directly to patients, many of whom already pay discounted prices for their drugs through their insurance coverage.

The Congressional Budget Office in October 2024 estimated that a plan similar to what Trump ended up adopting could reduce prescription drug prices by more than 5%, though the decrease “would probably diminish over time as manufacturers adjusted to the new policy by altering prices or distribution of drugs in other countries.”

The scope of the savings claimed by the Trump administration are likely to intensify the scrutiny by Democrats, who counter that any price reductions would be offset by higher costs for prescription drugs not covered by the “most favored nation” framework. One of their main critiques is that pharmaceutical companies have increased their profit margins while working with the administration.

In April, staff working for Sen. Bernie Sanders, I-Vt., released an analysis that looked at 15 of the companies that have agreed to this drug-pricing plan and found that their combined profits jumped 66% over the past year to $177 billion. The report noted that the tax cuts Trump signed into law last year “exempted or delayed many of the most expensive drugs” from price negotiations with Medicare.

The Trump administration has countered that they consider Sanders’ critique to be flawed, saying that it’s based on the list prices for pharmaceutical drugs instead of the actual price that patients pay.

Boak writes for the Associated Press.

Source link

Hegseth’s Day 2 clash with Democrats in Congress over Iran war

Defense Secretary Pete Hegseth clashed with Democratic lawmakers in Congress for a second day Thursday, rejecting senators’ accusations that the Iran war was launched without evidence of an imminent threat and waged with no coherent strategy.

The three-hour hearing of the Senate Armed Services Committee mostly traced the well-worn positions of Republicans and Democrats on the conflict, Hegseth’s leadership and the ways in which President Trump has used the American military.

In his opening statements, Hegseth called Democratic lawmakers “reckless naysayers” and “defeatists from the cheap seats” who have failed to recognize the many successes of the U.S. military against the Islamic Republic.

Hegseth said Trump has had the courage “unlike other presidents to ensure that Iran never gets a nuclear weapon and that their nuclear blackmail never succeeds. We have the best negotiator in the world driving a great deal.”

Democrats peppered Hegseth with questions about his efforts to remake military culture, U.S. support for Ukraine and whether Trump would seek congressional approval for the war. The Defense secretary said the ceasefire postpones the deadline for securing such approval.

Hegseth seemed to emerge with solid Republican support, though a few GOP senators asked about the dismissal of a top Army general and sought assurances that the Pentagon is doing everything possible to prevent civilian deaths.

The hearing was convened to discuss the Trump administration’s 2027 military budget proposal, which would boost defense spending to a historic $1.5 trillion. Hegseth and the chairman of the Joint Chiefs of Staff, Gen. Dan Caine, emphasized the need for more drones, missile defense systems and warships.

Top Democrat argues that war has left U.S. in worse position

Sen. Jack Reed, the committee’s ranking Democrat, argued that the war has left the U.S. in a worse strategic position, with 13 American troops killed, more than 400 injured and equipment destroyed.

The Strait of Hormuz remains closed, sending fuel prices skyrocketing, Reed said. Iran still has enriched uranium and retains enough combat effectiveness to keep the conflict locked in an impasse, while Iran’s hard-line government is still in charge.

“I am concerned that you have been telling the president what he wants to hear instead of what he needs to hear,” Reed said. “Bold assurances of success are a disservice to both the commander in chief and the troops who risked their lives based on them.”

Reed also lambasted Hegseth for his firing of top military leaders and suggested the Defense secretary had failed to recognize the accomplishments of women and people of color in the military. Reed noted that 60% of about two dozen officers fired by Hegseth have been female or Black.

Hegseth said that any firing is based on performance and that previous Pentagon leaders “were focused on social engineering, race and gender in ways that we think were unhealthy for the department.”

Republican chairman offers warmer welcome

Hegseth received a warmer welcome from Sen. Roger Wicker, the Republican chairman of the committee, and other GOP lawmakers. Wicker kicked off the hearing by noting that the U.S. is in the most dangerous security environment since World War II.

Through the war against Iran, Trump “has worked to remove the regime’s conventional military capabilities and force it back to the table for a permanent solution,” Wicker said.

He also commended the budget proposal for 2027, saying it “is chock-full of important programs and initiatives that are absolutely necessary to secure American interest in the 21st century.”

Sen. Deb Fischer, a Republican from Nebraska, praised Hegseth’s statement on the need for nuclear deterrence as well as the development of Trump’s Golden Dome missile defense program.

“For years, this committee has known that we must improve our ability to defend our homeland against a wider variety of threats,” Fischer said.

Sen. Tom Cotton, an Arkansas Republican, asked Hegseth whether he ever lied to Trump, pushing back against Reed’s claim that Hegseth tells the president what he wants to hear.

“I only tell the truth to the president,” Hegseth said.

Questions about civilian deaths

Senators also focused on civilian deaths in the Iran war and the Pentagon decision to hollow out a congressionally mandated office set up specifically to reduce civilian casualties.

The Associated Press has reported that growing evidence points to U.S. culpability for a deadly strike on an Iranian elementary school adjacent to a Revolutionary Guard base that killed more than 165 people, including children.

Democratic Sen. Kirsten Gillibrand of New York asked Hegseth, “What is your response to targeting that has resulted in the destruction of schools, hospitals, civilian places? Why did you cut by 90% the division that’s supposed to help you not target civilians?”

Hegseth responded that the Pentagon has an “ironclad commitment” to do more than other countries to prevent civilian deaths.

A day earlier, he battled with Democrats during a nearly six-hour House Armed Services Committee hearing, where he faced sharp questioning over the war’s costs in dollars, lives and diminishing stockpiles of crucial weapons.

Hegseth said Wednesday that the strike on the Iranian school remains under investigation.

War powers resolutions fail to pass

Democrats have called the conflict a costly war of choice that lacks congressional approval or oversight. But they have failed to pass multiple war powers resolutions that would have required Trump to halt the conflict until Congress authorizes further action.

Under the War Powers Act of 1973, Congress must declare war or authorize use of force within 60 days — a deadline that arrives Friday. The law provides for a potential 30-day extension, but the Republican administration has not indicated publicly whether Trump will seek it.

Sen. Tim Kaine, a Democrat from Virginia, asked Hegseth whether Trump will seek congressional authorization or ask for the 30-day extension. The Defense secretary said the clock pauses during a ceasefire. Kaine disagreed based on his reading of the law.

The Trump administration is in “active conversations” with lawmakers on addressing the 60-day timeline, according to a White House official, who spoke on condition of anonymity to discuss private deliberations.

Finley, Groves and Kinnard write for the Associated Press. Kinnard reported from Columbia, S.C. AP writer Seung Min Kim contributed to this report.

Source link

Democrats call for review of Paramount’s Middle Eastern financial backers

Democratic lawmakers are demanding scrutiny into Paramount Skydance’s financial backers amid rising concerns about potential foreign influence of U.S. media properties.

In a letter this week to Federal Communications Commission Chairman Brendan Carr, seven U.S. senators criticized Carr’s suggestion that Paramount’s $111-billion bid for Warner Bros. Discovery, backed by billionaire Larry Ellison and his family, was on a fast track to receive FCC approval with scant oversight.

Such complicated mergers typically receive an intense government review. The proposed merger would combine two legendary film studios, dozens of cable channels, HBO, CBS and two major news organizations, CNN and CBS News.

Ellison and his son, David, who chairs Paramount, are friendly with President Trump, who has long agitated for changes at CNN, which is slated to be absorbed by Paramount.

The company has said it expects to complete the deal by the end of September.

The Democrats expressed concerns that the fix may be in. Trump’s Justice Department has been reviewing whether the merger would violate U.S. antitrust laws, but a key deadline passed last month without comment from the department’s antitrust regulators.

Also at issue is the Middle Eastern money the Ellison family has been expecting to pull off Paramount’s leveraged buyout of its larger entertainment company rival. The acquisition would leave the combined company with nearly $80 billion in debt.

Late last year, Paramount disclosed that it had lined up $24 billion from wealth funds representing the royal families of Saudi Arabia, Qatar and Abu Dhabi, who would then become equity partners in the combined company.

Paramount has described the funds as largely passive investors, saying the royal families would not have input into corporate decision-making. They also would not control seats on the Paramount-Warner board.

Congressional Democrats previously have warned about potential national security concerns. The senators, led by Cory Booker (D-N.J.) and Chuck Schumer (D-N.Y.), remain concerned, particularly because the transaction will help shape the future of Hollywood production and the direction of key news outlets, including CNN, which maintains a strong presence around the world.

Members of the party have called on Carr to conduct “a full and independent” analysis of the foreign ownership interests before signing off on the merger. The FCC could play an important role, they said, because the tie-up includes Paramount-owned CBS, which holds FCC broadcast station licenses.

Paramount declined to comment. FCC officials did not respond to a request for comment.

Booker and Schumer pointed to Carr’s comments at an industry conference in Spain earlier this month. During an appearance at the Mobile World Congress, Carr suggested the Paramount-Warner deal could be swiftly approved because the foreign investment would warrant only a “very quick, almost pro forma review,” Carr reportedly said.

The FCC has a duty to examine foreign ownership, the lawmakers said, referencing the U.S. Communications Act, which forbids owners from outside the U.S. from holding more than 25% of the equity or voting interests in an entity that maintains an FCC license.

The lawmakers mentioned the FCC’s move earlier this year to tighten its foreign ownership framework to bolster transparency.

Paramount has not yet disclosed its final list of equity partners.

The company previously disclosed its proposed partners in Securities & Exchange Commission filings. However, last month, the composition of the Paramount-Warner deal changed when Larry Ellison agreed to fully guarantee the $45.7-billion in equity needed to finance the $31-a-share buyout of Warner investors.

Before Ellison stepped up, Warner board members had expressed concerns about Paramount’s financing. The tech billionaire’s increased involvement helped carry the Paramount deal over the finish line. Netflix bowed out Feb. 26, ceding the prize to Paramount.

Still, Paramount is expected to line up billions of dollars from outside investors.

It would be significant if Saudi Arabia’s Public Investment Fund, the Qatar Investment Authority and Abu Dhabi’s L’imad Holding Co., contributed $24 billion to the deal, the Democrats wrote.

“This is not incidental capital, it represents roughly one-fifth of the total transaction value,” Booker and the others wrote. “And it is not clear that this will be the only foreign investment.”

Initially, Paramount included Chinese technology company Tencent Holdings as a minority investor, but Paramount later removed Tencent from the investor pool due to concerns about its problematic status — it has been blacklisted by the U.S. Department of Defense.

Bloomberg News reported earlier this month that Tencent might return to the fold.

“This constellation of foreign investment from China and from Gulf States, with complex and sometimes competing relationships with the United States, demands rigorous, not perfunctory review,” Booker and the others wrote.

The letter also was signed by Sens. Dick Durbin (D-Ill.), Elizabeth Warren (D-Mass.), Richard Blumenthal (D-Conn.), Sheldon Whitehouse (D-R.I.) and Mazie K. Hirono (D-Hawaii).

They keyed in on the role of Saudi Arabia’s sovereign wealth fund, saying it was controlled by Crown Prince Mohammed bin Salman “whom the U.S. intelligence community concluded ordered the murder of Washington Post journalist Jamal Khashoggi in 2018.”

The proposed $24-billion investment would give “these governments a significant financial stake in the future content, licensing, and strategic decisions of a combined entity that includes some of the most-watched news and entertainment networks in America.”

It is also unclear whether the current tensions in the Middle East over the Iran war will have an impact on Paramount’s investor syndicate.

Trump’s son-in-law Jared Kushner, a proposed Paramount investor, also withdrew late last year.

Paramount shares held steady at $9.17. The company’s stock is down 31% since Feb. 27, when the company prevailed in the Warner auction.

Source link

Democrats storm out of Justice Department leaders’ briefing on the Epstein files

Democratic lawmakers on Wednesday stormed out of a closed-door briefing on the Jeffrey Epstein files by Justice Department leaders, and said they would push to force Atty. Gen. Pam Bondi to answer questions under oath about the case that has plagued the Trump administration.

Bondi and Deputy Atty. Gen. Todd Blanche went to Capitol Hill to try to quell bipartisan frustration over the Justice Department’s handling of millions of files related to Epstein’s sex trafficking investigation.

But less than an hour into the briefing, Democrats walked out in protest of the arrangement and said they would press to enforce a subpoena for Bondi to appear for a sworn deposition next month.

“We want her under oath because we do not trust her,” said Democratic Rep. Maxwell Frost.

Asked by reporters after the briefing whether she would comply with the subpoena, Bondi said, “I made it crystal clear I will follow the law.” She also defended the department’s handling of the Epstein files, saying officials are proud of their work to release millions of documents to the public.

The committee’s Republican chairman, Rep. James Comer, accused Democrats of political grandstanding.

“This for us, for the Republicans, it’s about getting answers,” Comer said after the briefing. “For the Democrats, it’s a political game, and they just demonstrated that today. There’s no reason for them to walk out and clutch their pearls and act like they were offended and outraged.”

Justice Department leaders had hoped the release of documents tied to the disgraced financier would put an end to a political saga that has dogged the president’s second term, but the agency remains consumed by questions and criticism over Epstein’s case and its management of the files. Bondi has accused Democrats of using the furor over the documents to distract from Trump’s political successes, even though some of the most vocal criticism has come from members of the president’s own party.

Five Republicans on the committee voted with Democrats to support the subpoena for Bondi to appear for a deposition on April 14. Lawmakers have accused the Justice Department of withholding too many files and criticized the agency for haphazard redactions that exposed intimate details about victims.

The Justice Department has called the subpoena “completely unnecessary,” noting that members of Congress have been invited to view unredacted files at the Justice Department and that department leaders have made themselves available to answer questions from lawmakers.

The department has sought to assure lawmakers and the public that there has been no effort to shield President Trump, who says he cut ties with Epstein years ago after an earlier friendship, or any other high-profile figures close to Epstein from potential embarrassment. Justice Department leaders have also rejected suggestions that they have ignored victims and insist that while there is no evidence in the files to prosecute anyone else, they remain committed to investigating should new information come forward.

“I’m not trying to defend Epstein — I’m not,” Blanche said in an interview this week with Katie Miller, who is married to top Trump advisor Stephen Miller. “I do defend the work that this department is doing today, right now, which is going after every single perpetrator anyway, and if there is a narrative that exists that we are ignoring Epstein victims, that is false.”

The documents were disclosed under the Epstein Files Transparency Act, the law enacted after months of public and political pressure that requires the government to open its files on the late financier and his confidant and onetime girlfriend, Ghislaine Maxwell. Maxwell, 64, was convicted in December 2021 and sentenced to 20 years in prison for her role over a decade in sexually exploiting and abusing underage girls with Epstein.

Criminal investigations into the financier have long animated online sleuths, conspiracy theorists and others who have suspected government cover-ups and clamored for a full accounting.

After missing a Dec. 19 deadline set by Congress to release all the files, the Justice Department said it tasked hundreds of lawyers with reviewing the records to determine what needed to be redacted, or blacked out. The Justice Department in January said it was releasing more than 3 million pages of documents along with more than 2,000 videos and 180,000 images.

Richer and Groves write for the Associated Press.

Source link